CRISPR/Cas9 gene editing in gastric cancer: Mechanisms, advances, and therapeutic potential

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Gastric cancer (GC) is a major global health concern, driving the need for advanced diagnostic and therapeutic strategies.
• Gene-editing technologies like CRISPR/Cas9 present novel opportunities for understanding GC's molecular underpinnings.

Purpose of the Study:

• To review the current applications of CRISPR/Cas9 technology in gastric cancer research.
• To explore the potential of CRISPR/Cas9 for developing novel gene-based therapies for GC.
• To discuss the challenges and future directions of CRISPR/Cas9 in GC management.

Main Methods:

• Review of current literature on CRISPR/Cas9 applications in gastric cancer research.
• Analysis of CRISPR/Cas9's role in identifying oncogenes, tumor suppressors, and modeling tumor microenvironment.
• Evaluation of gene editing advancements for understanding GC pathogenesis and therapeutic resistance.

Main Results:

• CRISPR/Cas9 has been instrumental in identifying key molecular players in GC development and progression.
• Genome editing has deepened the understanding of GC resistance mechanisms to existing therapies.
• CRISPR/Cas9 shows promise for developing targeted gene therapies for gastric cancer.

Conclusions:

• CRISPR/Cas9 technology is a powerful tool for advancing gastric cancer research and precision medicine.
• Addressing challenges like off-target effects, delivery, and ethical considerations is crucial for clinical translation.
• This technology holds significant potential to revolutionize the prevention, diagnosis, and treatment of gastric cancer.